Global Injectable Nanomedicines Market Projected to Attain Impressive Value of US $ 400 Million by 2029 End

  • 03 Jul 2019

Global injectable nanomedicines market to value over USD 400 Million by 2029 end and register a CAGR of over 8% from 2019 to 2029. 

Nanomedicines are minute sized drugs used specifically to target some section, having minimal toxic effects, and more effective. These drugs are administered orally or intravenously, while others are pure and injectable, given in small volumes.

These drugs provide better disease management with specific targeted drug delivery which is estimated to lead to a higher demand for injectable nanomedicines. The efficient and compact design of nanoparticles is becoming increasingly popular and expanding the market. For instance, liposomal technologies are employed by firms for extended-release drug delivery thereby decreasing the number of dosages. These include DepoFoam TM Technology, Non-PEGylated Technology (NPL) and others. These technologies improve patient drug adherence through decreased dosing and minimal side effects. To further elucidate, quick ready adoption of advanced technologies for manufacturing unique medicines is expected to support revenue growth of injectable nanomedicines market over the forecast period.

Government funds are increasing which is attracting other firms, expanding the market. In this regard, the U.S. Federal Authorities have provided funding worth US$ 1.4 Bn under the National Nanotechnology Initiative, confirming the growing importance and interest on nanomedicines. The growing use and application of nanomedicines is the cause behind this, helping the market to expand globally. Scientific and technological expertise coupled with strong academic research ensures better drug development. This factor is expected to boost the injectable nanomedicines industry favourably with faster market outreach.

Global Injectable Nanomedicines Market Segmentation

By Drug Type
●    Liposomes
●    Micelles
●    Nanocrystals
●    Polymeric Nanoparticles
●    Metallic Nanoparticles
●    Mesoporous Silica Nanoparticles
●    Others 

By Application
●    Cancers
●    Central Nervous System Diseases
●    Cardiovascular diseases
●    Infection Control
●    Inflammatory Diseases
●    Others

 By End User
●    Hospitals
●    Ambulatory Surgical Centers
●    Clinics
●    Specialized Drugs R&D Institutes
●    Managed Care Organizations

By Region:
●    Europe  
●    North America  
●    APAC  
●    Latin America
●    Rest of World 
North America is likely to lead the global injectable nanomedicines market in the near future. This is attributed to the increasing focus on diseases surveillance and the availability of progressive healthcare facilities. The market of injectable nanomedicine in Europe is expected to rise considerably due to the high availability of GMP certified sterile manufacturing facilities.
The developing regions in the Asia Pacific are also anticipated to expand the global injectable nanomedicines market. Growing prevalence of various infectious diseases and increasing investment in the healthcare sector in developing economies to further fuel growth in this market. 

Competitive Landscape:  
●    Tier 1 players- established companies in the market with a major market share  
●    Tier 2 players 
●    Emerging players which are growing rapidly 
●    New Entrants  
The significant firms operating in the injectable nanomedicines market are Merck KGaA, Amgen Inc., Pfizer Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and  Bausch & Lomb Incorporated. Emerging players operating in the injectable nanomedicines market are focusing on new marketing strategies in order to expand their product footprint in the global injectable nanomedicines market. They are investing in R&D for development of innovative nanomedicines, currently, there are several injectable nanomedicines under clinical trials and are expected to launch in recent years which is likely to upsurge the competition in injectable nanomedicine market.

FutureWise Key Takeaways  
●    Growth prospects 
●    SWOT analysis 
●    Key trends 
●    Key data points affecting market growth  

Objectives of the Study: 
●    To provide an exhaustive analysis on injectable nanomedicines by drug type, by application and region
●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
●    To evaluate and forecast micro-markets and overall market  
●    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa 
●    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies 


Get unlimited analyst support and customise this study further to your requirements, contact